http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2017, Vol. 26 ›› Issue (6): 404-412.DOI: 10.5246/jcps.2017.06.044

• 【研究论文】 • 上一篇    下一篇

液相色谱-串联质谱测定裸鼠血浆中21-羟基地夫可特的高灵敏方法及其在药物动力学研究中的应用

姚庆宇2, 李健2, 姚烨2, 陈镕2, 陈文君2, 苏红2, 杨亮2, 薛钧升2, 卢炜1,2, 周田彦1,2*   

  1. 1. 北京大学医学部 药学院 分子药剂学与新释药系统北京市重点实验室, 北京 100191
    2. 北京大学医学部 药学院 药剂学系, 北京 100191
  • 收稿日期:2017-03-09 修回日期:2017-05-10 出版日期:2017-06-29 发布日期:2017-05-20
  • 通讯作者: Tel./Fax: +86-010-82801717, E-mail: tianyanzhou@bjmu.edu.cn
  • 基金资助:
    National Natural Science Foundation of China (NSFC, Grant No. 81673500).

A highly sensitive LC-MS/MS method for the determination of 21-hydroxy deflazacort in nude mice plasma and its application to a pharmacokinetic study

Qingyu Yao2, Jian Li2, Ye Yao2, Rong Chen2, Wenjun Chen2, Hong Su2, Liang Yang2, Junsheng Xue2, Wei Lu1,2, Tianyan Zhou1,2*   

  1. 1. Beijing Key Laboratory of molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
    2. Department of Pharmaceutics, School of Pharmaceutical Science, Peking University Health Science Center, Beijing 100191, China
  • Received:2017-03-09 Revised:2017-05-10 Online:2017-06-29 Published:2017-05-20
  • Contact: Tel./Fax: +86-010-82801717, E-mail: tianyanzhou@bjmu.edu.cn
  • Supported by:
    National Natural Science Foundation of China (NSFC, Grant No. 81673500).

摘要:

本研究建立并验证了一种简单、灵敏的液质联用方法用于测定裸鼠血浆中21-羟基地夫可特的浓度, 并将此方法应用于药物动力学研究。选择倍他米松作为内标, 血浆样品采用乙腈进行蛋白沉淀处理之后, 用乙腈–4 mM甲酸铵溶液(用甲酸调节pH值至3.5, 40:60, v/v)作为流动相, C18反相色谱柱(50 mm×2 mm, 5 μm)中进行分离。质谱检测使用三重四级杆串联质谱, 电喷雾正离子模式、质谱多反应监测技术对待测物21-羟基地夫可特和内标物倍他米松分别在质核比为400.2/124.0393.3/147.0处进行检测。标准曲线的线性范围为0.5400 ng/mL (r>0.99), 日内日间的精密度为4.5%~10.1%, 准确度为–1.7%~10.7%。运用该方法成功地进行了雌性Balb/c裸鼠口服单次给药4 mg/kg地夫可特的临床前药物动力学研, 采用一级吸收二室模型描述其药物动力学行为。

关键词: 地夫可特, 21-羟基地夫可特, 液质联用, 裸鼠, 药物动力学

Abstract:

In the current study, we established and validated a simple and sensitive liquid chromatography-tandem mass spectrometricmethod for the determination of 21-hydroxy deflazacort in nude mice plasma, and such a method was applied to a pharmacokinetic study. Using betamethasone as the internal standard, the plasma samples were pre-treated by precipitation with acetonitrile and then analyzed on a reversed-phase C18 column (50 mm×2 mm, 5 μm) with a mobile phase consisting of acetonitrile and 4.0 mM ammonium formate (pH was adjusted to 3.5 with formic acid (40:60, v/v)). The analyte was detected by a triple quadrupole tandem mass spectrometer using electrospray, and multiple reaction monitoring was employed to select 21-hydroxy deflazacort at m/z 400.2/124.0 and betamethasone at m/z 393.3/147.0 in the positive ion mode. The calibration curves were linear (r>0.99) over the range of 0.5–400 ng/mL. The intra- and inter-day precisions and accuracies were 4.5%–10.1% and –1.7%~10.7% respectively. This method was successfully applied to a preclinical pharmacokinetic study of deflazacort on female nude mice administered with a single oral dose of 4 mg/kg deflazacort, and its pharmacokinetics was characterized by a two-compartment model with first-order absorption. 

Key words: Deflazacort, 21-Hydorxy deflazacort, LC-MS/MS, Nude mice, Pharmacokinetics

中图分类号: 

Supporting: